| 12365731 |
NKp46 binding agents |
Nadia Anceriz, Laurent Gauthier, Carine Paturel |
2025-07-22 |
| 12037392 |
Treatment regimens using anti-NKG2A antibodies |
Pascale Andre, Carine Paturel, CAROLINE SOULAS, Nicolai Wagtmann |
2024-07-16 |
| 11999784 |
Treatment of peripheral T cell lymphoma |
Cecile Bonnafous, HÉLÈNE SICARD, RENAUD BUFFET |
2024-06-04 |
| 11572410 |
Neutralization of inhibitory pathways in lymphocytes |
Pascale Andre, Carine Paturel, Nicolai Wagtmann |
2023-02-07 |
| 11377492 |
NKp46 binding agents |
Nadia Anceriz, Laurent Gauthier, Carine Paturel |
2022-07-05 |
| 11225519 |
Treatment of cancers using anti-NKG2A agents |
Pascale Andre, CAROLINE SOULAS, Nicolai Wagtmann |
2022-01-18 |
| 10870700 |
Neutralization of inhibitory pathways in lymphocytes |
Pascale Andre, CAROLINE DENIS, Carine Paturel, Nicolai Wagtmann |
2020-12-22 |
| 10711063 |
Neutralization of inhibitory pathways in lymphocytes |
Pascale Andre, Carine Paturel, Nicolai Wagtmann |
2020-07-14 |
| 10676523 |
Treatment regimens using anti-NKG2A antibodies |
Pascale Andre, Carine Paturel, CAROLINE SOULAS, Nicolai Wagtmann |
2020-06-09 |
| 10577416 |
Mica binding agents |
Laurent Gauthier, Ivan Perrot, Cecile Bonnafous |
2020-03-03 |
| 10494433 |
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma |
Pascale Andre, Cecile Bonnafous, Ashok K. Gupta, Luisa Salter-Cid, Michael Robbins |
2019-12-03 |
| 10344087 |
Treatment of peripheral T cell lymphoma |
Cecile Bonnafous, HÉLÈNE SICARD, RENAUD BUFFET |
2019-07-09 |
| 10329348 |
Treatment of cancers using anti-NKG2A agents |
Pascale Andre, CAROLINE SOULAS, Nicolai Wagtmann |
2019-06-25 |
| 9447185 |
Compositions and methods for treating proliferative disorders |
Francois Romagne, Alessandro Moretta, Petrus Johannes Louis Spee, Ulrik Morch |
2016-09-20 |